Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

We examine the relationship between product liability litigation and innovation by systematically combining data on …

This paper explores the economic incentives for medical procedure innovation. Using a proprietary dataset on billing … code applications for emerging medical procedures, we highlight two mechanisms that could hinder innovation. First, the … administrative hurdle of securing permanent, reimbursable billing codes substantially delays innovation diffusion. We find that …

Liability laws designed to compensate for harms caused by defective products may also affect innovation. We examine … negative impact on downstream innovation in medical implants, but it had no significant effect on upstream polymer patenting … effect on downstream innovation …

" about future performance and standard measures of corporate innovation. We begin by developing a career concern model where … probability of failure, are more likely to pursue innovation, and that this effect is larger in more competitive industries. We …

Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …

We study the causal impact of patent invalidation on subsequent innovation and exit by the patent holder. The analysis …

Cumulative innovation is central to economic growth. Do patent rights facilitate or impede follow-on innovation? We …. Patent rights block downstream innovation in computers, electronics and medical instruments, but not in drugs, chemicals or … triggers more follow-on innovation by small firms …